Z-1070-2018 Class II Terminated

Recalled by Stanbio Laboratory, LP — Boerne, TX

FDA device recall Z-1070-2018 was initiated by Stanbio Laboratory, LP on Feb 13, 2018 and is designated Class II. Reason for recall: All patient serum samples yield a weakly positive test result. The recall status is terminated (terminated Sep 27, 2018). Affected quantity: 686 units.

Recall details

Product Type
Devices
Report Date
Mar 21, 2018
Initiation Date
Feb 13, 2018
Termination Date
Sep 27, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
686 units

Product description

RaPET¿ RF Latex Reagent used as a component in the following kits: RaPET RF (1155-100, Control# 173201 expiry 2019-04-30) RF Latex (1156-001, Control# 172224 expiry 2019-12-31) RF Latex (1155L-100B, Control # 172701 expiry 2019-09-30 and Control # 173262 expiry 2019-12-31) Product Usage: RaPET¿ RF is intended for the qualitative and semiquantitative detection of rhematoid factor in human serum. The latex slide test is intended to be used as an aid in the diagnosis of rheumatoid arthritis.

Reason for recall

All patient serum samples yield a weakly positive test result.

Distribution pattern

Worldwide Distribution - United States nationwide , Canada, Korea, Mexico, Trinidad

Code information

Lot 21675

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1070-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1070-2018. Report a data issue: hello@regdatalab.com.